Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
about
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexiaNutrition in Pancreatic Cancer: A ReviewInsulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation?Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexiaFit with good fat? The role of n-3 polyunsaturated fatty acids on exercise performanceNew parenteral lipid emulsions for clinical useCancer cachexia: impact, mechanisms and emerging treatmentsInfluence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults.Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trialNeurobiology of inflammation-associated anorexia.Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice.Clinical anticachexia treatments.Novel treatments for cancer cachexia.A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.Nutrition modulation of cachexia/proteolysis.Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.Cancer cachexia: mechanisms and clinical implications.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatmentMolecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia.Nutritional interventions for cancer-induced cachexiaNutritional status of patients with locally advanced pancreatic cancer: a pilot study.Nursing management of nutrition in cancer and palliative care.Dietary polyunsaturated fatty acids and anorexia nervosa: is there a link?Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans.Role of omega-3 fatty acid supplementation in inflammation and malignancy.Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.The cancer cachexia syndrome: a review of metabolic and clinical manifestations.Toward a core nutraceutical program for cancer management.Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.Multi-targeted therapy of cancer by omega-3 fatty acids.Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic micePlasma polyunsaturated fatty acids and age-related physical performance decline.n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia.Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro.Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection.Potential applications of fish oils rich in n-3 fatty acids in the palliative treatment of advanced pancreatic cancer.
P2860
Q24246397-4D83AF2F-0C5E-4635-8A09-0178F089C42CQ26741097-9D73E4B9-F458-427C-A5C7-95ADC7684EF0Q26748802-743B0D5F-550E-40E2-8F46-341150EAAC98Q26827510-C03D9BB2-F6CC-425C-8207-568E32133E39Q28073362-98BE9C63-8DDE-4D36-8511-13E769EFF620Q28248812-D95576DD-C055-4909-8766-F7FBD55BE778Q28384479-6833583A-0653-4BFD-BC3B-D4D72527FAC2Q33657412-F8967A2A-4594-4482-9DE0-39C87BE5C8F0Q33755930-30876ACA-B48A-4C47-9BAD-49ADE5D41B58Q33806456-82EA6FFE-5BAF-4272-A4DB-11193353601FQ33968290-3F3F1691-F6E6-48FF-AF0D-7083F641932EQ33979314-3E065708-CF47-49FC-A1E1-03992F20038BQ33994400-A406FA14-CC62-4013-B1EB-694326774EABQ34005616-8749AAA9-C334-4180-83FA-31D85A75E17DQ34210506-21A08DD6-B431-4712-8512-D4AA2D449A2EQ34565917-46AED9B2-281D-4B48-941C-927AD9C04B24Q34583647-B98615A0-D840-4FD2-9C04-87966798E8F5Q34631019-23CD9130-3A89-4A68-9913-2AF35D706992Q34660312-414ACFBE-7EAD-4C1C-AF05-1C9EFAA8BE93Q34669440-4D5AD01A-D683-48EC-974C-60F8CEA2AE2EQ34764949-4D896D76-E941-4882-93C9-CB8E61EA1E5DQ35019743-FB15A226-172B-4D8A-AAA2-F3F4032FD437Q35112838-4B0C2AA2-4C19-4902-9B03-5D95A40A85DEQ35164155-C72A59B6-C4E7-4B36-ACB1-75CB3E5941AFQ35746297-CBF09CAB-54E2-485E-A38D-0884C7F57F81Q35769516-F69F605B-BBF2-4340-879E-7F33F8617DB6Q35785440-6EC35F31-AFE7-4B3B-9640-F5A5C5893B95Q35828425-7378D081-611F-4337-B0D6-97CCF002782CQ36278394-7CE17AC4-8103-4C79-83C3-8AA4AAFDC634Q36473648-534E034B-C086-4CB5-B0FB-36005A2D1C11Q36646456-D8BBAEC0-7023-406B-84B9-ED54C094FBB7Q36648384-170AA4C6-929B-41E2-B232-81D2BEFB0E0DQ36694660-12FFB04D-0BA4-401D-B047-7E1095B28B28Q36947010-B574B304-263D-413A-A55B-6B591484411FQ37123496-970DCEEF-9E7A-4878-B054-6A49A897E4F9Q37171906-EBAF3AAB-0A88-4553-828D-7C882BB5E67EQ37350075-3B58D8CA-D769-4660-AF99-1A292BCAABE6Q37624469-93C48BBD-526E-429B-B020-509947CCEFBDQ37729736-5DD0C675-F8BC-46B9-8849-BD440DB5ED7AQ37899960-1043A440-258B-4CF1-A829-E78181EF7FE1
P2860
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@ast
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@en
type
label
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@ast
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@en
prefLabel
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@ast
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
@en
P2093
P1433
P1476
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer
@en
P2093
P304
P356
10.1207/S15327914NC3602_6
P577
2000-01-01T00:00:00Z